$TRVN Trevana announced two publications of the respiratory safety data from the OLINVYK development program 7:04 AM ET 8/26/20 | Briefing.com Related Quotes
4:00 PM ET 8/27/20 Symbol Last % Chg TRVN 1.57 2.61% Real time quote.
Study Summary and Key Findings:
OLINVYK was associated with a higher probability of analgesia than respiratory depression, while the reverse was true for morphine. The clinical utility function model predicted there would be a lower probability of a respiratory event occurring with OLINVYK versus morphine.